Randomized prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic test-Reference-Cited by-同舟云学术

Randomized prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic test

Published:2021-09 Issue:9 Volume:23 Page:1689-1696
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Brockman Deanna G.^ORCID,Austin-Tse Christina A.,Pelletier Renée C.,Harley Caroline,Patterson Candace,Head Holly,Leonard Courtney Elizabeth,O’Brien Kimberly,Mahanta Lisa M.,Lebo Matthew S.,Lu Christine Y.,Natarajan Pradeep,Khera Amit V.,Aragam Krishna G.,Kathiresan Sekar,Rehm Heidi L.,Udler Miriam S.

Funder

Massachusetts General Hospital

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

https://www.nature.com/articles/s41436-021-01193-y.pdf

Reference34 articles.

1. 3.National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf (2020).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for reporting variants in novel candidate genes identified during clinical genomic testing;Genetics in Medicine;2024-10

2. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis;Genetics in Medicine;2024-06

3. Genome sequencing as a generic diagnostic strategy for rare disease;Genome Medicine;2024-02-14

4. Considerations for reporting variants in novel candidate genes identified during clinical genomic testing;2024-02-09

5. Genome sequencing as a generic diagnostic strategy for rare disease;2023-09-28